Citation Impact
Citing Papers
Zinc Finger Nucleases as tools to understand and treat human diseases
2010
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.
1997
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs
2019 StandoutNobel
Hedgehog signalling in cancer formation and maintenance
2003 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis
2003
Directed evolution: new parts and optimized function
2009 StandoutNobel
Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation
2017
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
2013 Standout
Molecular pathogenesis of lung cancer
1999
Controlling and enhancing CRISPR systems
2020 StandoutNobel
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
2017 StandoutNature
Identification of O-GlcNAc Modification Targets in Mouse Retinal Pericytes: Implication of p53 in Pathogenesis of Diabetic Retinopathy
2014
Mechanically Activated Ion Channels
2015 StandoutNobel
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
The coming of age of de novo protein design
2016 StandoutNatureNobel
p21 in cancer: intricate networks and multiple activities
2009 Standout
Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials
2011
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis
2001
Long non-coding RNAs and cancer: a new frontier of translational research?
2012
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
2002
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005 Standout
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers
1999
The hallmarks of cancer
2012 Standout
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome
2005 Standout
The roles of K+ channels in cancer
2013
A TALE nuclease architecture for efficient genome editing
2010 Standout
Exosomal proteins as potential diagnostic markers in advanced non‐small cell lung carcinoma
2015
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
2001 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
1999
Molecular Pathogenesis of Lung Cancer
2002
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non–Small-Cell Lung Cancer
2002
X-Tile
2004 Standout
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer
2002
Light-Inducible Spatiotemporal Control of Gene Activation by Customizable Zinc Finger Transcription Factors
2012
p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
1997
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Chemical Glycoproteomics
2016 StandoutNobel
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of A-R Yoon being referenced
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
2009
Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.
1995
MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region
2011
Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors
2007
Molecular characterization of apoptosis induced by CARF silencing in human cancer cells
2010